Stay updated on Quizartinib in Children & Young Adults With AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.

Latest updates to the Quizartinib in Children & Young Adults With AML Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.4.2 to the record history and removed the prior government funding notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoChange DetectedA site-wide funding notice was added, informing that data may not be up to date due to a government funding lapse. The history page shows a new revision tag (v3.4.1) with the previous revision (v3.4.0) removed.SummaryDifference0.5%

- Check20 days agoChange DetectedThe update adds a glossary display and color-coded change indicators (green for additions, red for deletions) and updates the revision label to v3.4.0, while the previous v3.3.4 label is removed.SummaryDifference0.7%

- Check34 days agoChange DetectedThe history was updated to include Revision: v3.3.4 and to remove Revision: v3.3.3; this reflects housekeeping of the log rather than changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer/history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAn added Revision: v3.3.2 appears in the page history and a Revision: v3.2.0 was removed, indicating a minor site maintenance update. This does not alter study data or how the record is presented.SummaryDifference0.1%

Stay in the know with updates to Quizartinib in Children & Young Adults With AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib in Children & Young Adults With AML Clinical Trial page.